Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Talk:Pallotta 2022 Abstract Bioblast"

From Bioblast
Line 1: Line 1:
[[File:Bioblast2022 banner.jpg|link=Bioblast_2022]]
[[File:Bioblast2022 banner.jpg|link=Bioblast_2022]]
== Comments by two reviewers ==
== Comments by two reviewers ==
 
[[Aasander Frostner E]]
::::::* My recommendation is: Accept (although conditional) for inclusion as a poster. Explanation: The abstract lifts an interesting and relevant topic for the conference, and the mentioned study (if explained in more detail) should offer some new insights, but it should only be accepted if the author makes a rigorous revision of the English.
::::::* My recommendation is: Accept (although conditional) for inclusion as a poster. Explanation: The abstract lifts an interesting and relevant topic for the conference, and the mentioned study (if explained in more detail) should offer some new insights, but it should only be accepted if the author makes a rigorous revision of the English.



Revision as of 13:17, 26 May 2022

Bioblast2022 banner.jpg

Comments by two reviewers

Aasander Frostner E
  • My recommendation is: Accept (although conditional) for inclusion as a poster. Explanation: The abstract lifts an interesting and relevant topic for the conference, and the mentioned study (if explained in more detail) should offer some new insights, but it should only be accepted if the author makes a rigorous revision of the English.
Garcia-Roves PM
  • After evaluating the abstract my suggestions is to be rejected, in the current form. English should be significantly improved. A better description of the experimental design and results is needed in order to be considered for a resubmission and proper evaluation (if possible).

Comments by the Editor

Gnaiger E 2022-05-26
  • The concerns of the two reviewers have to be addressed.
References
  1. Pallotta ML (2014) NMN, an intermediate in the salvage pathway, helps to increase the intramitochondrial NAD+ concentration in yeast and influences NAD+/NADH ratio: possible function as metabolic read-out 65. Mosbacher Kolloquium - Molecular Protein Quality Control in Health, Aging and Disease, German Society for Biochemistry and Molecular Biology, Mosbach Germany 26th-29th March 2014
  2. Pallotta ML (2014) Mitochondrial NAD pool ad metastasis. Cells, proteins and bioprocessing (Nature) London (England) 17th-19th June 2014
  3. Pallotta ML (2015) The Aquarian Age in cancer therapy: biobankers, biomarkers, and much more↔getting of the root of the problem ↔NAD+ an ancient metabolite with surprising modernity ↔Mitochondrial NAD pool, tumour microenvironment and metastasis. Cell Symposia, Multifaceted Mitochondria, Chicago July 19-21, 2015
  4. Pallotta ML (2016) Monitoring NAD(P)H levels and their relevance to bioenergetics using fluorescence-based strategies in salivary samples: a possible biomarker in the detection of cancer and precancer. EUSTM 2016; on New Horizons in Translational Medicine
  • The above references were removed from the abstract, since they are not (easily) available to the general reader, and appear to be abstracts presented at various conferences rather than properly citable publications with DOI.
  • "In 2007 Sinclair’ group referred to .." - a full reference should be included to the corresponding publication.
NMN or NaMN, NMNAT and NADK
  • Provide full names.